Correction: A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy
RSC Chemical Biology · 2026 · 7 (11) · 2309-2311
DOI: 10.1039/d6cb90040b ↗Kurz gefasst
Korrektur in der Zeitschrift RSC Chemical Biology, 2026. Verfasst von Qi Xue und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), …. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Correction for ‘A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy’ by Qi Xue et al. , RSC Chem. Biol. , 2025, 6 , 1284–1296, https://doi.org/10.1039/D5CB00096C.
Autor:innen und Institutionen
- State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), Nanjing University Nanjing China jieli@nju.edu.cn.
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd., BioBay, Building C23 218 Xinghu Street, Suzhou Industrial Park Suzhou Jiangsu China tingxu@alphamabonc.com.
Förderung
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Xue, Q., Peng, J., Dai, W., Wu, Q., Jiao, J., Hu, Y., Sha, W., Yang, Y., Yu, W., Liu, S., Xu, T., & Li, J. P. (2026). Correction: A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy. RSC Chemical Biology, 7(11), 2309-2311. https://doi.org/10.1039/d6cb90040b
Vancouver
Xue Q, Peng J, Dai W, Wu Q, Jiao J, Hu Y, et al. Correction: A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy. RSC Chemical Biology. 2026;7(11):2309-2311. doi:10.1039/d6cb90040b
BibTeX
@article{Xue2026,
author = {Xue, Qi and Peng, Jianjian and Dai, Wenying and Wu, Qingsong and Jiao, Jinbiao and Hu, Yudi and Sha, Wanxing and Yang, Yang and Yu, Wenhao and Liu, Siyang and Xu, Ting and Li, Jie P},
title = {Correction: A biparatopic HER2-targeting ADC constructed via site-specific glycan conjugation exhibits superior stability, safety, and efficacy},
journal = {RSC Chemical Biology},
year = {2026},
volume = {7},
number = {11},
pages = {2309--2311},
doi = {10.1039/d6cb90040b}
}
EUVIMED